Revolution Medicines RVMD
Todd Cislini Jeffrey (Officer) plans to sell 1,799 RVMD shares, about $79,525
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-25-007482
- Approximate sale date: Sep 24, 2025
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Restricted Stock Units
- 10b5-1 plan adopted: Mar 13, 2025
Written from the Form 144 on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
